Device Trial Radar · NCT05064553
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Last checked: Nov 19, 2026Latest source record: Oct 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
2,990
Actual
Start
Jul 26, 2021
Primary completion
Sep 12, 2025
Study completion Dec 2026
Sponsor
- Lead sponsor
- Exact Sciences CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 1, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to assess overall sensitivity and specificity of Oncoguard™ Liver for hepatocellular cancer (HCC) detection in a surveillance population.
Conditions
- Hepatocellular Carcinoma
- Hepatocellular Cancer
- Hepatitis B
- Cirrhosis
- Liver Cancer
Interventions
Study CT/MRI ImagingDevice
Subjects with negative ultrasound will be sent for a study CT/MRI.
Standard of Care CT/MRI ImagingDevice
Subjects with positive ultrasound are anticipated to have standard of care imaging follow-up as well as other procedures as needed.
Oncoguard™ Liver TestDiagnostic test
Subjects will have a blood sample collected for the Oncoguard™ Liver Test.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To demonstrate that Oncoguard™ Liver early-stage HCC sensitivity is non-inferior to that of ultrasound within a 5% marginTime frame: A maximum of 30 days from study or standard-of-care CT or MRI exam.
- To demonstrate that Oncoguard™ Liver HCC specificity exceeds 82%Time frame: A maximum of 30 days from study or standard-of-care CT or MRI exam.
Locations
76 sites in 1 country. Site status is shown where the registry gives one.
Arizona Health Research
Chandler, Arizona
Arizona Digestive Health - Sun City
Sun City, Arizona
Franco Felizarta, MD
Bakersfield, California
73 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.